Comparaison of 3 Protocols of Ocytocin Administration in C Section
NCT ID: NCT04046510
Last Updated: 2019-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2018-09-01
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxytocin Administration During Cesarean Section
NCT03344302
Continuous Infusion for Pain Relief
NCT02711072
Outcomes After the Implementation of a New Oxytocin Protocol
NCT02722356
The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery
NCT03967171
Comparative Study Between Oxytocin Infusion Before and After Placental Delivery on Blood Loss During and After Cesarean Delivery .
NCT06889155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim was to determine the lowest efficient dose to prevent post partum hemorrage and with the lowest incidence of maternal side effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High doses
the patients of this group recieved conventionnal doses of ocytocin after foetal extraction in C section: 5IU in bolus followed by 15IU in continuous infusion
Ocytocin
Administration of lower doses of Ocytocin in bolus and continuous infusion
Intermediate doses
the patients of this group recieved after foetal extraction in C section: 2IU in bolus followed by 10IU in continuous infusion
Ocytocin
Administration of lower doses of Ocytocin in bolus and continuous infusion
Low doses
the patients of this group recieved after foetal extraction in C section: 2IU in bolus followed by 5 IU in continuous infusion
Ocytocin
Administration of lower doses of Ocytocin in bolus and continuous infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ocytocin
Administration of lower doses of Ocytocin in bolus and continuous infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* non conscent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mongi Slim Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mhamed Sami Mebazaa
Professor head of the anesthesia and intensive care department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mongi Slim Hospital
Tunis, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ocytocin in c section
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.